BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2016
View Archived Issues
PDS Biotechnology's PDS-0101 shows promise in phase I/IIa study
Read More
Vertex advances plans for next-generation correctors for cystic fibrosis
Read More
Bayer compares BAY-1003803 formulations in psoriasis plaque test
Read More
Theravance Biopharma reports data from phase I MAD study of TD-0714
Read More
Lexicon Pharmaceuticals reports positive results for phase II trial of sotagliflozin
Read More
Moleculin Biotech announces positive data for WP-1122 toxicity testing in mice
Read More
Debiopharm International completes phase II trial of Debio-1450
Read More
Sanofi, WRAIR and Fiocruz agree principles of collaboration for Zika vaccine development
Read More
Minerva Neurosciences reports data for phase IIb trial of MIN-101
Read More
[225Ac]PSMA-617 as promising new PSMA-targeted radiation therapy for mCRPC
Read More
Entasis Therapeutics starts phase I trial of ETX-2514
Read More
Novel radioligands show promise as imaging and therapeutic agents for GRPR-expressing tumors
Read More
ApeX Therapeutics changes corporate name to Apexian Pharmaceuticals
Read More
Changzhou Longthera Pharmaceuticals patents CDK/cyclin D1 inhibitors
Read More
Hangzhou Innogate Pharma discloses IDO-1 and/or TDO inhibitors
Read More
Selecta Biosciences doses first patient in phase II trial of SEL-212
Read More
Eli Lilly describes GOAT inhibitors
Read More
Merck & Co. develops FXIa and/or plasma kallikrein inhibitors
Read More
Allergan completes tender offer for Vitae Pharmaceuticals
Read More
Ultragenyx Pharmaceutical starts phase III trial of burosumab
Read More
Silvergate announces U.S. availability of Qbrelis
Read More
New BRAC2 mutation characterized in a family with male and female breast cancer
Read More
Apitope enrolls first patient in phase I trial of ATX-GD-59
Read More
Boehringer Ingelheim discloses topline data from phase III trial of BI-695501
Read More
Myriad RBM to work with Sanofi to perform biomarker analysis of blood samples from ELIXA trial
Read More
Serodus, Lam Therapeutics and Actelion receive FDA orphan designations for treatments in PAH
Read More
MYH3 gene variants may cause congenital scoliosis
Read More
